canakinumab

Spain

Drugs containing this active substance

  • ILARIS 150 MG/ML SOLUTION FOR INJECTION

    It is used to treat various inflammatory diseases, such as periodic fever syndromes (CAPS, TRAPS, HIDS/MKD, and familial Mediterranean fever), Still's disease (including adult-onset Still's disease and systemic juvenile idiopathic arthritis), and arthritic gout in adults.

    Form: solution for injection

    Active substance Dosage
    canakinumab 150 mg

    ATC: L04A L04AC L04AC08

    Manufacturer: Novartis Europharm Limited